Dana V. Devine

10.4k total citations
216 papers, 6.6k citations indexed

About

Dana V. Devine is a scholar working on Hematology, Biochemistry and Management of Technology and Innovation. According to data from OpenAlex, Dana V. Devine has authored 216 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Hematology, 86 papers in Biochemistry and 56 papers in Management of Technology and Innovation. Recurrent topics in Dana V. Devine's work include Blood transfusion and management (86 papers), Blood donation and transfusion practices (56 papers) and Platelet Disorders and Treatments (52 papers). Dana V. Devine is often cited by papers focused on Blood transfusion and management (86 papers), Blood donation and transfusion practices (56 papers) and Platelet Disorders and Treatments (52 papers). Dana V. Devine collaborates with scholars based in Canada, United States and United Kingdom. Dana V. Devine's co-authors include Katherine Serrano, Donald E. Brooks, Peter Schubert, E.J. Levin, Pieter R. Cullis, Arcadio Chonn, Rajesh K. Kainthan, Johan Janzen, Lorna M. Williamson and Brankica Culibrk and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Dana V. Devine

212 papers receiving 6.4k citations

Peers

Countries citing papers authored by Dana V. Devine

Since Specialization

Citations

This map shows the geographic impact of Dana V. Devine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana V. Devine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana V. Devine more than expected).

Fields of papers citing papers by Dana V. Devine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana V. Devine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana V. Devine. The network helps show where Dana V. Devine may publish in the future.

Co-authorship network of co-authors of Dana V. Devine

This figure shows the co-authorship network connecting the top 25 collaborators of Dana V. Devine. A scholar is included among the top collaborators of Dana V. Devine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana V. Devine. Dana V. Devine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization and Hemocompatibility of α, β, and γ Cyclodextrin-Modified Magnetic Nano-Adsorbents 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Dana V. Devine, Larry D. Unsworth	3
2	Measurement of lead, mercury, and cadmium in blood donors in Canada 2024 ·Transfusion ·Narges Hadjesfandiari, Katherine Serrano, (unknown), Vilte Barakauskas, Qilong Yi, Michael Murphy, Dana V. Devine	1
3	Hemocompatibility of β-Cyclodextrin-Modified (Methacryloyloxy)ethyl Phosphorylcholine Coated Magnetic Nanoparticles 2023 ·Biomolecules ·(unknown), (unknown), (unknown), Katherine Serrano, Dana V. Devine, Larry D. Unsworth	9
4	Cold-stored platelets for acute bleeding in cardiac surgical patients: a narrative review 2023 ·Canadian Journal of Anesthesia/Journal canadien d anesthésie ·(unknown), Keyvan Karkouti, Miki Peer, Marina Englesakis, Philip C. Spinella, Torunn Oveland Apelseth, (unknown), Walter H.A. Kahr, Mark J. McVey, Vivek Rao, Lusine Abrahamyan, Lani Lieberman, H.E. Mewhort, Dana V. Devine, Jeannie Callum, Justyna Bartoszko	5
5	What influences decisions to donate plasma? A rapid review of the literature 2023 ·Vox Sanguinis ·(unknown), Adam Easterbrook, Kelly Holloway, Dana V. Devine, Nick Bansback	5
6	Early and out‐of‐hospital use of COVID‐19 convalescent plasma: An international assessment of utilization and feasibility 2022 ·Vox Sanguinis ·Arwa Z. Al‐Riyami, Lise J Estcourt, Naomi Rahimi‐Levene, Evan M. Bloch, Ruchika Goel, Pierre Tiberghien, (unknown), Mie Topholm Bruun, Dana V. Devine, Richard R. Gammon, Silvano Wendel, (unknown), (unknown), (unknown), Íñigo Romón, Karin van den Berg, Junichi Kitazawa, Gopal Kumar Patidar, Cynthia So‐Osman, Erica M. Wood, (unknown)	4
7	National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies 2022 ·Transfusion ·Jerry A. Holmberg, Stephen Henry, Thierry Burnouf, Dana V. Devine, Susanne Marschner, Thomas E. Boothby, Scott R. Burger, Stella T. Chou, Brian Custer, Neil Blumberg, Donald L. Siegel, Steven L. Spitalnik	0
8	Assessing the quality of stored red blood cells using handheld Spatially Offset Raman spectroscopy with multisource correlation analysis 2022 ·Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy ·Martha Z. Vardaki, H. Georg Schulze, Katherine Serrano, Michael W. Blades, Dana V. Devine, Robin F. B. Turner	12
9	Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols 2017 ·Transfusion ·(unknown), Peter Schubert, Katherine Serrano, Cedric J. Carter, Brankica Culibrk, Dana V. Devine	13
10	Altered timing of riboflavin and ultraviolet light pathogen inactivation improves platelet in vitro quality 2017 ·Transfusion ·Peter Schubert, Brankica Culibrk, (unknown), Katherine Serrano, E.J. Levin, Qilong Yi, Thomas Thiele, Andreas Greinacher, Susanne Marschner, Dana V. Devine	9
11	Proceedings of a Consensus Conference: Risk-Based Decision Making for Blood Safety 2011 ·Transfusion Medicine Reviews ·(unknown), Morris A. Blajchman, Gilles Delage, Margaret Fearon, Dana V. Devine	20
12	Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study 2011 ·Transfusion ·Rebecca Cardigan, Pieter F. van der Meer, (unknown), (unknown), (unknown), José A. Cancelas, Dana V. Devine, H. Gulliksson, Ralph Vassallo, Janny De Wildt‐Eggen	39
13	Performance characteristics of a novel blood bag in‐line closure device and subsequent product quality assessment 2010 ·Transfusion ·Katherine Serrano, E.J. Levin, Brankica Culibrk, (unknown), (unknown), Wolfgang Boecker, Dana V. Devine	5
14	A comparative study of common techniques used to measure haemolysis in stored red cell concentrates 2009 ·Vox Sanguinis ·(unknown), Katherine Serrano, Dana V. Devine	111
15	A signaling pathway contributing to platelet storage lesion development: targeting PI3‐kinase–dependent Rap1 activation slows storage‐induced platelet deterioration 2009 ·Transfusion ·Peter Schubert, Jonathan N. Thon, (unknown), (unknown), Edwin D.W. Moore, Dana V. Devine, Juergen Kast	32
16	Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions 2003 ·JAMA ·Paul C. Hébert, Dean Fergusson, Morris A. Blajchman, George A. Wells, Andrew Kmetic, Doug Coyle, Nancy M. Heddle, Marc Germain, Mindy Goldman, Baldwin Toye, Irwin Schweitzer, (unknown), Dana V. Devine, Graham D. Sher, (unknown)	254
17	Idiopathic immune-mediated acquired von Willebrand's disease in a patient with angiodysplasia: Demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor 1999 ·American Journal of Hematology ·(unknown), Dana V. Devine, (unknown), Stephen H. Nantel, Cedric J. Carter	31
18	Idiopathic immune‐mediated acquired von Willebrand's disease in a patient with angiodysplasia: Demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor 1999 ·American Journal of Hematology ·(unknown), Dana V. Devine, (unknown), Stephen H. Nantel, Cedric J. Carter	3
19	Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems 1999 ·Transfusion ·Dana V. Devine, Amanda J. Bradley, Elisabeth Maurer, E.J. Levin, (unknown), Katherine Serrano, Maria I.C. Gyöngyössy‐Issa	35
20	Thrombosis in systemic lupus erythematosus: The role of antiphospholipid antibody 1999 ·Arthritis & Rheumatism ·(unknown), John M. Esdaile, Dana V. Devine	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact